Hong Wu

Director, Cell/Transgenic Mice Shared Resource at Jonsson Comprehensive Cancer Center

Hong Wu

Hong Wu

Director, Cell/Transgenic Mice Shared Resource at Jonsson Comprehensive Cancer Center

Overview
RelSci Relationships

656

Number of Boards

1

Relationships
RelSci Relationships are individuals Hong Wu likely has professional access to. A relationship does not necessarily indicate a personal connection.

University of California - Los Angeles

Relationship likelihood: Strong

Associate Professor in Residence, Department of Medicine, Hematology & Oncology at University of California, Los Angeles - David Geffen School of Medicine

Relationship likelihood: Strong

Professor, Department of Molecular & Medical Pharmacology at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Assistant Professor, Department of Urology at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Chief of Urologic Oncology at West Los Angeles Veterans Affairs Medical Center

Relationship likelihood: Strong

Assistant Director, JCCC Community Applications of Research at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Professor at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Co-Founder at Milken Family Foundation

Relationship likelihood: Strong

Research Director-Urologic Sciences Department at University of British Columbia

Relationship likelihood: Strong

Medical Director at Prostate Cancer Foundation

Relationship likelihood: Strong

Paths to Hong Wu
Potential Connections via
Relationship Science
You
Hong Wu
Director, Cell/Transgenic Mice Shared Resource at Jonsson Comprehensive Cancer Center
Career History
Director, Cell/Transgenic Mice Shared Resource
Current
Scientific Advisor
Current

Applied StemCell, Inc. is a biotechnology company. Its products include stem cell research, genome editing products for cell line generation, primary cells from patient samples and isogenic cell lines. The company was founded by Ruhong Jiang, Ruby Yanru Chen-Tsai and Michael Cleary and is headquartered in Milpitas, CA.

Boards & Committees
Member, Research Award Review Committee
Current

The Prostate Cancer Foundation (PCF), formerly known as CaP CURE, is the world’s largest philanthropic source of support for prostate cancer research. PCF was founded in 1993 in order to discover better treatments and a cure for prostate cancer. As of 2012, PCF has raised more than $500 million for research and funded more than 1,600 research projects at nearly 200 institutions in 17 countries. In the past 2 years, 5 new drugs that extend the lives of men with metastatic prostate cancer have been approved by the FDA. PCF initiated and supported academic treatment science that fast-forwarded every one of these approvals.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hong Wu. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hong Wu's profile does not indicate a business or promotional relationship of any kind between RelSci and Hong Wu.